1. 223PUsing PSMA PET/CT to assess response in metastatic prostate cancer (mPC) patients (pts) receiving upfront chemohormonal therapy. (25th November 2018) Authors: Anton, A; Ballok, Z; Bowden, P; Costello, T; Harewood, L; Corcoran, N; Dundee, P; Peters, J; Lawrentschuk, N; Troy, A; Webb, D; Chan, Y; See, A; Siva, S; Murphy, D; Hofman, M S; Tran, B Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗